Comprehensive behavioral analysis and quantification of brain free amino acids of C57BL/6J congenic mice carrying the 1473G allele in tryptophan hydroxylase-2.


Journal

Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700

Informations de publication

Date de publication:
03 2019
Historique:
received: 12 09 2018
revised: 22 10 2018
accepted: 23 10 2018
pubmed: 26 11 2018
medline: 21 8 2020
entrez: 26 11 2018
Statut: ppublish

Résumé

Tryptophan hydroxylase 2 (Tph2) is a rate-limiting enzyme for the biosynthesis of 5-hydroxytryptamine (5-HT, serotonin). Previous studies have reported that C1473G polymorphism of the murine Tph2 gene leads to decreased 5-HT levels in the brain and abnormal behavioral phenotypes, such as impaired anxiety- and depression-like behaviors. In this study, to confirm the effect of the C1473G polymorphism on mouse phenotypes, we conducted a comprehensive battery of behavioral tests and measured the amounts of brain free amino acids involved in the production of 5-HT. We obtained C57BL/6J congenic mice that were homozygous for the 1473G allele of Tph2 (1473G) and subjected them and their wild-type littermates (1473C) to a battery of behavioral tests. Using reverse-phase high-performance liquid chromatography (HPLC), we measured the amounts of free amino acids in the 5-HT and epinephrine synthetic/metabolic pathways in the frontal cortex, hippocampus, striatum, and midbrain. We failed to detect significant differences between genotypes in depression-like behaviors, anxiety-like behaviors, social behaviors, sensorimotor gaiting, or learning and memory, while 1473G mice exhibited a nominally significant impairment in gait analysis, which failed to reach study-wide significance. In the HPLC analysis, there were no significant differences in the amounts of 5-HT, dopamine, norepinephrine, and epinephrine in the frontal cortex, hippocampus, striatum, and midbrain. Our findings do not support the idea that congenic C57BL/6J mice carrying the 1473G allele may represent an animal model of mood disorder under normal conditions without stress.

Identifiants

pubmed: 30472790
doi: 10.1002/npr2.12041
pmc: PMC7292325
doi:

Substances chimiques

Amino Acids 0
Serotonin 333DO1RDJY
Tph2 protein, mouse EC 1.14.16.4
Tryptophan Hydroxylase EC 1.14.16.4
Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-60

Informations de copyright

© 2018 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.

Références

Neurosci Lett. 2017 Feb 15;640:105-110
pubmed: 28069454
Neurosci Lett. 2010 Aug 30;481(1):6-11
pubmed: 20600620
Eur J Neurosci. 2005 Aug;22(4):997-1000
pubmed: 16115223
J Neurosci Res. 2009 Apr;87(5):1168-74
pubmed: 19006079
Neurosci Lett. 2008 Jan 24;431(1):21-5
pubmed: 18082956
Neuropharmacology. 2014 Oct;85:73-80
pubmed: 24863038
Mol Brain. 2018 May 10;11(1):27
pubmed: 29747665
Science. 2003 Jan 3;299(5603):76
pubmed: 12511643
Neuropsychopharmacol Rep. 2018 Mar;38(1):18-36
pubmed: 30106265
Science. 2004 Jul 9;305(5681):217
pubmed: 15247473
Neuropsychopharmacology. 2012 Aug;37(9):1986-98
pubmed: 22491354
Neuropsychopharmacol Rep. 2019 Mar;39(1):56-60
pubmed: 30472790
Psychopharmacology (Berl). 2011 Feb;213(2-3):509-20
pubmed: 21181117
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5530-4
pubmed: 3475690
Neuropsychopharmacol Rep. 2018 Jun;38(2):52-60
pubmed: 30106261
Genes Brain Behav. 2010 Jul;9(5):537-43
pubmed: 20398061
Neuropsychopharmacol Rep. 2018 Sep;38(3):133-144
pubmed: 30175526

Auteurs

Hisatsugu Koshimizu (H)

Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.

Nao Hirata (N)

Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.

Keizo Takao (K)

Life Science Research Center, University of Toyama, Toyama, Japan.

Keiko Toyama (K)

Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.

Takashi Ichinose (T)

Department of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.

Shigeki Furuya (S)

Department of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.

Tsuyoshi Miyakawa (T)

Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH